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INTRODUCTION
Placental sulphatase deficiency/congenital ichthyosis is an X-linked inborn error
of metabolism which was first described in 1969 by France and Liggins.1 It is
an enzymatic defect affecting steroid metabolism, clinically manifested by
diminished oestrogen production during fetal life and by congenital ichthyosis
post-natally. This disorder has a reported incidence of between 1: 6,000 and
1: 10,000 males.
CASE HISTORY
A 33-year-old woman presented at the Jubilee Maternity Unit, Belfast City
Hospital, at 27 weeks' gestation and this was confirmed by ultrasonic scan. Her
weight was 68.8 kg, blood pressure 110/80 mm Hg, haemoglobin 14.2 g/dl,
blood group 0 (Rhesus-negative), and no atypical red cell antibodies were
detected. The patient claimed to smoke 15 cigarettes perday. She had previously
had a 12-week spontaneous abortion followed by a successful pregnancy.
Throughout that pregnancy she was recorded as losing weight; labour was
induced at 41 weeks and five days, and after an eight-hour labour she had a
forceps delivery of a 2750 g female infant.
In her present pregnancy she was reviewed at 32 weeks' gestation and then two
weeks later when, because of a weight loss of 2 kg and proteinuria, she was
admitted for fetal assessment. Ultrasonic scan, cardiotochography, maternal
kick-chart, haemoglobin and serum human placental lactogen were all satis-
factory. A midstream sample of urine showed a significant urinary tract infection
which required treatment. The urinary oestriol/creatinine ratio was reported as
0.9 nmol/pmol (normal >5); this was repeated and wasconsistently low (Fig. 1).
In view of the markedly low urinary oestriol results, the diagnosis of placental
sulphatase deficiency was raised. Further enquiry revealed a family history of
'dry skin' affecting only male members (Fig. 2). Deficiency of the sulphatase
enzyme was confirmed by the intravenous administration of 50 mg dehydro-
epiandrosterone sulphate (DHEAS), an oestrogen precursor. Serum oestradiol
was measured at 5, 10, 15, 20, 30, 60 and 120 minutes following this and
revealed no change from the pre-injection level of 5.0 nmol/l. Twenty-four hours
later, 50 mg ofdehydroepiandrosterone (DHEA) wasadministered intravenously.
This compound does not require a sulphatase enzyme and serum oestradiol rose
from the base line of5.0 nmol/I to a maximum 175 nmol/l afteronly 10 minutes.
Following this, serum oestradiol declined slowly to 50 nmol/l after 2 hours. This
significant rise in serum oestradiol following the injection of DHEA but not that of
DHEAS was evidence that there was placental sulphatase deficiency.
© The Ulster Medical Society, 1985.Placental sulphatase deficiency
* BI PARIETAL DIAMETERS
LI O/C RATIO
50%
0 0*
0
7.0'
6.5
6.0
'6
0 *5
*4 M
*3 -4
0
2
~~ ~ o[ - j_1
5.5- g r I I I I I ~~~~I
24 26 28 30 32 34 36 38 40
GESTATION IN WEEKS
FIGURE 1. Urinary oestriol/creatinine (o/c) ratio and fetal bi-parietal diameter from week 24 to 38.
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*- - FAMILY STUDIED FIGURE 2. Family prevalence of ichthyosis or dry skin.
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Ultrasonic scan was unsuccessful in determining the sex of the fetus. The patient
was allowed to go home and was reviewed weekly. She was re-admitted at 371/2
weeks' gestation, having lost a further 2 kg. Her blood pressure had risen to
140/90 mm Hg and proteinuria persisted. Serial ultrasonic scans demonstrated
intrauterine growth retardation (IUGR) with an estimated fetal weight of 2 kg.
Repeated urinary oestriol/creatinine ratios (0/C) remained low. It was decided to
terminate the pregnancy by forewater amniotomy and intravenous syntocinon
infusion. She laboured slowly at first, with a long latent phase of five hours, and
required a lumbar epidural anaesthetic. Following this the cervix soon reached
full dilatation. Because of fetal distress, she had a forceps delivery of a healthy
male infant weighing 2125 grams. He showed no skin abnormality at birth but by
the age of six weeks he was already developing severe ichthyosis.
The placenta was retained and removed manually. A specimen of one cotyledon
was frozen and sent for enzyme analysis. The results confirmed a sulphatase
deficiency with normal microsomal and lysosomal enzymes.
DISCUSSION
The human placenta in isolation is incapable of oestrogen synthesis without
assistance from the fetal liver and the adrenal cortex. DHEAS is the major
oestrogen precursor produced by the fetal and maternal adrenal glands. It is
converted by the enzyme 3 13-hydroxysteroid sulphatase which removes the
sulphate group, leaving the neutral C-19 steroid nucleus which is then aromatised
to oestrogen.
Prenatally, steroid sulphatase deficiency leads to reduced oestrogen production
in spite of which pregnancy continues and is often prolonged. No antenatal
danger has yet been shown and the low oestrogens themselves are not an
indication for early interference. However, in this case, concomitant intrauterine
growth retardation pointed to the need for induction. The low level of oestrogen,
as in the anencephalic fetus, often delays the onset of labour, especially in the
primigravida.2 The cervix is slow to dilate, with an increase in cervical dystocia,
which leads to a higher rate of Caesarean section.
Postnatally the enzyme deficiency caused an accumulation of cholesterol
sulphate in the blood, cornea and skin leading to the development within the first
year of ichthyosis and corneal opacities.
The genetic locus for this condition is found on the short arm of the
X-chromosome attheXg blood group locus and is one ofthe few genesthat is not
subject to inactivation. This family's pedigree is consistent with X-linkage. The
prenatal diagnosis of sulphatase deficiency must be considered when urinary
oestrogens are found to be low. There are many causes, such as drug therapy
(using corticosteroids, antibiotics, meprobamate, mondelamine) acute urinary
tractinfections, anencephally, congenital adrenocortical hypoplasia and incorrect
'dates' which can lead to a reduction in urinary oestrogens. If these are excluded,
sulphatase deficiency can be isolated as in this case by loading the patient with
DHEAS and DHEA and following the subsequent oestradiol responses.5 After
delivery, the placenta can beanalysed for deficient 3J3-hydroxysteroid sulphase.3
Affected individuals with X-linked ichthyosis will have a marked (15 to 30 times)
elevation of serum cholesterol sulphate.4 Therapeutically some relief is obtained
from topical urea preparations. Genetic counselling and reassurance remain
important in the management of patients with this disorder.
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